Rather, the addition of MDMs to our multi-cellular models synergized toward enhanced tumor-directed CD4 and CD8 T cell trafficking, signifying a supportive role for TAMs in augmenting activated T cell homing toward tumor targets. The gene discussed is CD8A; the disease is neoplasm.